Patient-derived heavy chain antibody targets cell surface HSP90 on breast tumors

BACKGROUND: Monoclonal antibodies have been used to effectively treat various tumors. We previously established a unique strategy to identify tumor specific antibodies by capturing B-cell response against breast tumor antigens from patient-derived sentinel lymph nodes. Initial application of this ap...

Descripción completa

Detalles Bibliográficos
Autores principales: Devarakonda, Charan V., Kita, Daniel, Phoenix, Kathryn N., Claffey, Kevin P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559304/
https://www.ncbi.nlm.nih.gov/pubmed/26334999
http://dx.doi.org/10.1186/s12885-015-1608-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559304/
https://www.ncbi.nlm.nih.gov/pubmed/26334999
http://dx.doi.org/10.1186/s12885-015-1608-z

Ejemplares similares